Review of the Consumption of Medicines for the Treatment of Musculoskeletal and Connective Tissue Diseases in the Period from 2010 to 2018 in Slovenia
Keywords:
musculoskeletal diseases, analgesics, medicines consumption, medicines prescriptionAbstract
Due to their high incidence, diseases of the musculoskeletal system and connective tissue represent an economic burden on society and a growing public health problem. These diseases are treated with various medicines, the consumption of which says a lot about the health, economic and social characteristics of these diseases; knowledge of the use of medicines is crucial when planning the allocation of financial resources. The purpose of the present study was to assess the consumption of medicines for the treatment of musculoskeletal diseases and their economic value in the period from 2010 to 2018 in Slovenia. Therefore, a retrospective observational study was performed to assess the prescription and consumption of medicines. The consumption of these medicines in Slovenia increased in that period, although fewer prescriptions were prescribed for these diseases. The consumption of medicines from the group of non-steroidal anti-inflammatory and anti-rheumatic medicines, and medicines for the treatment of gout increased the most. In 2018, around 1.2 million prescriptions, worth almost €17.4 million, were issued, which represents a significant contribution to the economic burden of these diseases.
References
Babatunde, O. O., Jordan, J. L., Van der Windt, D. A., Hill, J. C., Foster, N. E. and Protheroe, J. (2017). Effective treatment options for musculoskeletal pain in primary care: A systematic overview of current evidence. PloS ONE, 12, št. 6, e0178621.
Enthoven, W. T. M., Roelofs, P. D. D. M., Deyo, R. A., van Tulder, M. W. and Koes, B. W. (2016). Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev, 2, CD012087.
EUMUSC. NET. Pridobljeno dne 30. 3. 2021 s svetovnega spleta: http://www.eumusc.net/about_background.cfm.
Eurostat. European Health Interview Survey. (2021). Pridobljeno dne 30. 3. 2021 s svetovnega spleta: https://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=hlth_ehis_cd1d&lang=en.
Fransen, M., McConnell, S., Harmer, A.R., Van der Esch, M., Simic, M. and Bennell, K. L. (2015). Exercise for osteoarthritis of the knee. Cochrane Database of Syst Rev 2015(1): CD004376.
Gov.UK. Public Health England. (2021). Pridobljeno dne 1. 4. 2021 s svetovnega spleta: https://www.gov.uk/government/publications/musculoskeletal-health-applying-all-our-health/musculoskeletal-health-applying-all-our-health.
Gross, A., Kay, T. M., Paquin, J. P., Blanchette, S., Lalonde, P., Christie, T. idr. (2015). Exercises for mechanical neck disorders. Cochrane Database Syst Rev, 2015, 1, CD004250.
Hartfiel, N., Clarke, G., Havenhand, J., Phillips, C. and Edwards, R. T. (2017). Cost-effectiveness of yoga for managing musculoskeletal conditions in the workplace. Occupational Medicine, 67, str. 687–695. doi:10.1093/occmed/kqx161
Jelenc, M. (2013). Značilnosti predpisovanja zdravil pacientom z največjim številom predpisanih receptov v Sloveniji v letu 2011 (Diplomska naloga). Ljubljana: Medicinska fakulteta Univerze v Ljubljani.
Kostnapfel Rihtar, T. and Korošec, A. (2014). Pomen spremljanja porabe zdravil v zdravstvenem sistemu. V: Poraba ambulantno predpisanih zdravil leta 2014 v Sloveniji. Ljubljana: NIJZ.
Lewis, R., Gómez Álvarez, C., Rayman, M., Lanham - New, S., Woolf, A. and Mobasheri, A. (2019). Strategies for optimising musculoskeletal health in the 21st century. BMC Musculoskeletal Disorders, 20, str. 1–15.
Loveless, M. S. and Fry, A. L. (2016). Pharmacological therapies in musculoskeletal conditions. Med Clin North Am, 100, št. 4, str. 869–890.
Malanga, G. and Wolff, E. (2008). Evidence-informed management of chronic low back pain with nonsteroidal antiinflammatory drugs, muscle relaxants, and simple analgesics. Spine J, 8, št. 1, str. 173–184.
Minetto, M. A., Giannini, A., McConnell, R., Busso, C., Torre, G. and Massazza, G. (2020). Common Musculoskeletal Disorders in the Elderly: The Star Triad. J Clin Med, 9, str. 1216.
MKB-10. Mednarodna klasifikacija bolezni in sorodnih zdravstvenih problemov za statistične namene. (2005). Ljubljana: Inštitut za varovanje zdravja.
Nacionalni inštitut za javno zdravje. (2019). Podatkovni portal. Pridobljeno dne 1. 4. 2021 s svetovnega spleta: URL: https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal?px_language=sl&px_db=NIJZ+podatkovni+portal&rxid=2e787901-db5c-48a2-8cdd-f1445854a33e.
Simonović, S. (2020). Predlog pristopa h krepitvi kostno-mišičnega zdravja v Sloveniji (Specialistična naloga). Ljubljana: Zdravniška zbornica Slovenije.
Štabuc, B., Tepeš, B., Skok, P., Vujasinović, M., Blinc, A., Čerček, M., Tomšič, M. and Markovič, S. (2015) Smernice za preprečevanje in zdravljenje neželenih učinkov nesteroidnih protivnetnih in antiagregacijskih učinkovin na prebavila. Zdrav Vestn, 84, str. 3–15.
WHO. Musculoskeletal conditions. Pridobljeno dne 9. 4. 2021 s svetovnega spleta: https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions.
WHO. Defined daily dose. Definition and general considerations. Pridobljeno dne 9. 4. 2021 s svetovnega spleta: https://www.who.int/tools/atc-ddd-toolkit/about-ddd.
Zakon o zbirkah podatkov s področja zdravstvenega varstva (2000). Uradni list Republike Slovenije, št. 65. Pridobljeno dne 30. 3. 2021 s svetovnega spleta: http://www.pisrs.si/Pis.web/pregledPredpisa?id=ZAKO1419.
ZZZS. Centralna baza zdravil. Pridobljeno dne 8. 4. 2021 s svetovnega spleta: https://partner.zzzs.si/wps/portal/portali/aizv/e-poslovanje/centralna_baza_zdravil/.
